RxDoctor Payments Data

Bryan Piccirillo, MD

Interventional Cardiology · Hartford, CTNPI 1134449606

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,040 of the $11,617 with a category attached, or 60.6%. 16 manufacturers reported payments, led by Boston Scientific at 52.4% of the total.

$11,617in general payments, 2019–2025

Across 266 payments — averaging $43.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$6K
  • Edwards Lifesciences$3K
  • Medtronic$1K
  • Abbott$556
  • AstraZeneca$129
  • Amgen$112
  • plus $331 from 10 others
$22,404in research payments, 2019–2025

Across 7 payments — averaging $3200.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$22K

What the payments were for

  • Travel & lodging$4,57839%
  • Food & beverage$7,04061%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,617 in reported general payments places this provider in the 65th percentile of 73 interventional cardiology providers in Connecticut.

See all interventional cardiology providers in Connecticut

Medicare billing

Part B allowed, 2024
$92,994
Medicare patients
138
Services billed
300

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Hartford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →